The roles and applications of short-chain fatty acids derived from microbial fermentation of dietary fibers in human cancer

Dietary fibers (DFs) and their metabolites attract significant attention in research on health and disease, attributing to their effects on regulating metabolism, proliferation, inflammation, and immunity. When fermented by gut microbiota, DFs mainly produce short-chain fatty acids (SCFAs), such as acetic acid, propionic acid, and butyric acid. As the essential nutrients for intestinal epithelial cells, SCFAs maintain intestinal homeostasis and play essential roles in a wide range of biological functions. SCFAs have been found to inhibit histone deacetylase, activate G protein-coupled receptors, and modulate the immune response, which impacts cancer and anti-cancer treatment. Notably, while extensive studies have illuminated the roles of SCFAs in colorectal cancer development, progression, and treatment outcomes, limited evidence is available for other types of cancers. This restricts our understanding of the complex mechanisms and clinical applications of SCFAs in tumors outside the intestinal tract. In this study, we provide a comprehensive summary of the latest evidence on the roles and mechanisms of SCFAs, with a focus on butyric acid and propionic acid, derived from microbial fermentation of DFs in cancer. Additionally, we recapitulate the clinical applications of SCFAs in cancer treatments and offer our perspectives on the challenges, limitations, and prospects of utilizing SCFAs in cancer research and therapy.

[1]  M. Okpeku,et al.  ‘Multi-omics’ data integration: applications in probiotics studies , 2023, NPJ science of food.

[2]  J. Mathers Dietary fibre and health - the story so far. , 2023, The Proceedings of the Nutrition Society.

[3]  K. Siedlecka-Kroplewska,et al.  Microbiota-derived metabolites in colorectal cancer patients in preoperative period. , 2023, European review for medical and pharmacological sciences.

[4]  F. Roviello,et al.  Sodium butyrate in both prevention and supportive treatment of colorectal cancer , 2022, Frontiers in Cellular and Infection Microbiology.

[5]  Chenyang Zhao,et al.  Synergistic effects of sodium butyrate and cisplatin against cervical carcinoma in vitro and in vivo , 2022, Frontiers in Oncology.

[6]  M. Kiechle,et al.  Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial. , 2022, The American journal of clinical nutrition.

[7]  A. Mondino,et al.  Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy , 2022, Journal for ImmunoTherapy of Cancer.

[8]  F. Ciardiello,et al.  Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab , 2022, International journal of cancer.

[9]  Xi-jun Wang,et al.  Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects , 2022, Frontiers in Oncology.

[10]  Jared C Malke,et al.  Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response , 2021, Science.

[11]  Q. Feng,et al.  Soluble Dietary Fiber, One of the Most Important Nutrients for the Gut Microbiota , 2021, Molecules.

[12]  K. Obama,et al.  Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion , 2021, Nature Communications.

[13]  W. Dong,et al.  Combining Sodium Butyrate With Cisplatin Increases the Apoptosis of Gastric Cancer In Vivo and In Vitro via the Mitochondrial Apoptosis Pathway , 2021, Frontiers in Pharmacology.

[14]  Soojin Lee,et al.  Anticancer Effects of Propionic Acid Inducing Cell Death in Cervical Cancer Cells , 2021, Molecules.

[15]  M. Shariati,et al.  Emerging role of nutritional short-chain fatty acids (SCFAs) against cancer via modulation of hematopoiesis , 2021, Critical reviews in food science and nutrition.

[16]  R. Cowles,et al.  Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease , 2021, Cells.

[17]  T. Gress,et al.  Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer , 2021, Nature Communications.

[18]  M. Szczyrek,et al.  Diet, Microbiome, and Cancer Immunotherapy—A Comprehensive Review , 2021, Nutrients.

[19]  Dake Wang,et al.  Propionate and Butyrate Produced by Gut Microbiota After Probiotic Supplementation Attenuate Lung Metastasis of Melanoma Cells In Mice. , 2021, Molecular nutrition & food research.

[20]  G. Netto,et al.  Gut Microbiota–Derived Short-Chain Fatty Acids Promote Prostate Cancer Growth via IGF1 Signaling , 2021, Cancer Research.

[21]  Jin Heon Jeon,et al.  Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel , 2021, Nature Biomedical Engineering.

[22]  M. Sohrabi,et al.  Role of microbiota-derived short-chain fatty acids in cancer development and prevention. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  R. Burgos,et al.  Participation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer , 2021, Frontiers in Physiology.

[24]  Fenglin Yin,et al.  Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy , 2021, Frontiers in Molecular Biosciences.

[25]  Glaucia Carielo Lima,et al.  Dietary fibers as beneficial microbiota modulators: A proposal classification by prebiotic categories. , 2021, Nutrition.

[26]  A. Galanis,et al.  Pro-biomics: Omics Technologies To Unravel the Role of Probiotics in Health and Disease. , 2021, Advances in nutrition.

[27]  N. Moniri,et al.  Short-chain free-fatty acid G protein-coupled receptors in colon cancer. , 2021, Biochemical pharmacology.

[28]  Yu-qin Mao,et al.  Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer , 2021, Theranostics.

[29]  E. Martínez-López,et al.  Effects of short chain fatty acids on metabolic and inflammatory processes in human health. , 2021, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[30]  H. Foo,et al.  Anti-cancer and anti-inflammatory effects elicited by short chain fatty acids produced by Escherichia coli isolated from healthy human gut microbiota , 2021, Microbial Cell Factories.

[31]  H. Heidari,et al.  Review of short-chain fatty acids effects on the immune system and cancer , 2020 .

[32]  K. Whelan,et al.  Dietary fibre in gastrointestinal health and disease , 2020, Nature Reviews Gastroenterology & Hepatology.

[33]  Yang-zhi Zhao,et al.  The protective role of short-chain fatty acids acting as signal molecules in chemotherapy- or radiation-induced intestinal inflammation. , 2020, American journal of cancer research.

[34]  S. B. Kim,et al.  Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient-derived organoids , 2020, International journal of oncology.

[35]  M. Weickert,et al.  The Health Benefits of Dietary Fibre , 2020, Nutrients.

[36]  David T. W. Tzeng,et al.  The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer , 2020, Cancer Immunology Research.

[37]  P. Newsholme,et al.  Butyrate, generated by gut microbiota, and its therapeutic role in metabolic syndrome. , 2020, Pharmacological research.

[38]  Bin Li,et al.  Effects of prebiotic dietary fibers and probiotics on human health: With special focus on recent advancement in their encapsulated formulations , 2020, Trends in Food Science & Technology.

[39]  D. Mallardo,et al.  Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer , 2020, Nature Communications.

[40]  Koichi Inoue,et al.  Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors , 2020, JAMA network open.

[41]  Jiaxin Liu,et al.  Sodium butyrate inhibits migration and induces AMPK‐mTOR pathway‐dependent autophagy and ROS‐mediated apoptosis via the miR‐139‐5p/Bmi‐1 axis in human bladder cancer cells , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  A. Ichimura,et al.  Free Fatty Acid Receptors in Health and Disease. , 2020, Physiological reviews.

[43]  D. Zheng,et al.  Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy , 2019, Nature Biomedical Engineering.

[44]  N. Kanayama,et al.  Oncoprotective Effects of Short-Chain Fatty Acids on Uterine Cervical Neoplasia , 2019, Nutrition and cancer.

[45]  Z. Li,et al.  Correlation between microbes and colorectal cancer: tumor apoptosis is induced by sitosterols through promoting gut microbiota to produce short-chain fatty acids , 2018, Apoptosis.

[46]  J. Lapek,et al.  Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer , 2018, Cell.

[47]  J. Garssen,et al.  Pro‐ and anti‐inflammatory effects of short chain fatty acids on immune and endothelial cells , 2018, European journal of pharmacology.

[48]  H. M. Kim,et al.  Microbial metabolites, short‐chain fatty acids, restrain tissue bacterial load, chronic inflammation, and associated cancer in the colon of mice , 2018, European journal of immunology.

[49]  Kassem M. Makki,et al.  The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease. , 2018, Cell host & microbe.

[50]  H. Hao,et al.  Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming * , 2018, Molecular & Cellular Proteomics.

[51]  Huihua Xia,et al.  Impact of a 3-Months Vegetarian Diet on the Gut Microbiota and Immune Repertoire , 2018, Front. Immunol..

[52]  M. Tavakoli-Yaraki,et al.  Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment , 2017, Lipids in Health and Disease.

[53]  E. Pistikopoulos,et al.  In vitro Studies. , 2017 .

[54]  D. Herr,et al.  Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells , 2017, PloS one.

[55]  Yong Wang,et al.  Effects of fiber and probiotics on diarrhea associated with enteral nutrition in gastric cancer patients , 2017, Medicine.

[56]  Soumen Roy,et al.  Microbiota: a key orchestrator of cancer therapy , 2017, Nature Reviews Cancer.

[57]  Han Liu,et al.  Microbiota metabolite short chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43 , 2016, Mucosal Immunology.

[58]  Chang H. Kim,et al.  Gut Microbial Metabolites Fuel Host Antibody Responses. , 2016, Cell host & microbe.

[59]  M. Chandrasekar,et al.  Inhibitors of histone deacetylase as antitumor agents: A critical review. , 2016, Bioorganic chemistry.

[60]  Nagendra Singh,et al.  Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. , 2016, Pharmacology & therapeutics.

[61]  Renan Corrêa-Oliveira,et al.  Regulation of immune cell function by short-chain fatty acids , 2016, Clinical & translational immunology.

[62]  T. Preston,et al.  Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.

[63]  Gianni Panagiotou,et al.  Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice , 2016, Proceedings of the National Academy of Sciences.

[64]  Wendy S. Garrett,et al.  Cancer and the microbiota , 2015, Science.

[65]  Chang H. Kim,et al.  Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation , 2014, Immune network.

[66]  V. Godfrey,et al.  A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. , 2014, Cancer discovery.

[67]  C. Jobin,et al.  Microbial-derived butyrate: an oncometabolite or tumor-suppressive metabolite? , 2014, Cell host & microbe.

[68]  B. Wilson,et al.  Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells , 2014, Cell.

[69]  S. Kang,et al.  Short chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway , 2014, Mucosal Immunology.

[70]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[71]  M. Côrte-Real,et al.  Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release , 2013, Cell Death and Disease.

[72]  Wei Sun,et al.  The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. , 2012, Molecular cell.

[73]  O. Feron,et al.  Gut microbiota-derived propionate reduces cancer cell proliferation in the liver , 2012, British Journal of Cancer.

[74]  Yinghe Hu,et al.  Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. , 2012, Journal of genetics and genomics = Yi chuan xue bao.

[75]  D. Faller,et al.  Butyrate Histone Deacetylase Inhibitors , 2012, BioResearch open access.

[76]  M. Dagli,et al.  Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer cells , 2012, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[77]  L. Cosgrove,et al.  A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate , 2012, British Journal of Nutrition.

[78]  Y. Lee,et al.  Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells , 2011, Oncology reports.

[79]  G. Dorta,et al.  [Prevention of colorectal cancer]. , 2011, Revue medicale suisse.

[80]  X. Coumoul,et al.  Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex , 2011, International journal of cancer.

[81]  D. Nie,et al.  G‐protein‐coupled receptor for short‐chain fatty acids suppresses colon cancer , 2011, International journal of cancer.

[82]  D. Nie,et al.  The role of short-chain fatty acids in orchestrating two types of programmed cell death in colon cancer , 2011, Autophagy.

[83]  Z. Liu,et al.  Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post‐operative infectious complications in colorectal cancer surgery – a double‐blind study , 2011, Alimentary pharmacology & therapeutics.

[84]  J. Lattimer,et al.  Effects of Dietary Fiber and Its Components on Metabolic Health , 2010, Nutrients.

[85]  Marco Braga,et al.  A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. , 2010, World journal of gastroenterology.

[86]  E. Barrett,et al.  Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. , 2009, The Journal of clinical endocrinology and metabolism.

[87]  G. Cresci,et al.  GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. , 2009, Cancer research.

[88]  S. Calderoni,et al.  Cholesterylbutyrate Solid Lipid Nanoparticles as a Butyric Acid Prodrug , 2008, Molecules.

[89]  S. Florian,et al.  Pectin does not inhibit intestinal carcinogenesis in APC-deficient Min/+ mice. , 2008, Journal of agricultural and food chemistry.

[90]  G. Howarth,et al.  Short-chain fatty acid modulation of apoptosis in the kato III human gastric carcinoma cell line , 2007, Cancer biology & therapy.

[91]  H. Keer,et al.  Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer. , 2004, Lung cancer.

[92]  R. Kuefer,et al.  Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer , 2004, British Journal of Cancer.

[93]  J. Davie Inhibition of histone deacetylase activity by butyrate. , 2003, The Journal of nutrition.

[94]  J. Galmiche,et al.  Molecular analysis of the effect of short-chain fatty acids on intestinal cell proliferation , 2003, Proceedings of the Nutrition Society.

[95]  E. Levy,et al.  Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway , 2003, Gut.

[96]  C. Britten,et al.  A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[97]  M. Grever,et al.  Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[98]  M. Nagane,et al.  Inhibitory Effects of Sodium Butyrate on Proliferation and Invasiveness of Human Glioma Cells , 2001, Neurosurgery.

[99]  D. Nowis,et al.  Antitumor activity of tributyrin in murine melanoma model. , 2001, Cancer letters.

[100]  R. Hautmann,et al.  Tributyrin induces differentiation, growth arrest and apoptosis in androgen‐sensitive and androgen‐resistant human prostate cancer cell lines , 2000, International journal of cancer.

[101]  D. Dickson The story so far… , 2000, Nature.

[102]  J. Fujimoto,et al.  Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo , 1998, International journal of cancer.

[103]  S. Meng,et al.  p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells , 1998 .

[104]  P. Gibson,et al.  Short-chain fatty acids promote the migration of colonic epithelial cells in vitro. , 1997, Gastroenterology.

[105]  W. Scheppach,et al.  Role of short-chain fatty acids in the prevention of colorectal cancer. , 1995, European journal of cancer.

[106]  E. Kurschel,et al.  Clinical pharmacology of sodium butyrate in patients with acute leukemia. , 1987, European journal of cancer & clinical oncology.

[107]  L. R. Jacobs Effect of dietary fiber on colonic cell proliferation and its relationship to colon carcinogenesis. , 1987, Preventive medicine.

[108]  R. Whitehead,et al.  Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). , 1986, Gut.

[109]  D. Dexter,et al.  Sodium butyrate-induced alteration of growth properties and glycogen levels in cultured human colon carcinoma cells , 1984, The Histochemical Journal.

[110]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[111]  Y. Obara,et al.  Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. , 2007, Cellular signalling.

[112]  S. Meng,et al.  p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[113]  C. Young,et al.  Butyrate and phenylacetate as differentiating agents: Practical problems and opportunities , 1995, Journal of cellular biochemistry. Supplement.

[114]  The health benefits of dietary fibre. , 1991, Nursing RSA = Verpleging RSA.